QuEra Computing, a neutral-atom quantum computing leader, has partnered with Quantum Intelligence Corp. (QIC), an AI-driven drug development company, to explore quantum technology in drug discovery. The terms and financial details of the agreement have not been disclosed.
The partnership will integrate QuEra's neutral atom-type quantum computers with QIC's QUEST platform to enhance drug development processes. This collaboration aims to improve the speed, precision, and efficiency of drug discovery by leveraging quantum computing power to boost AI-driven predictions of drug behavior, effectiveness, and safety.
QuEra's quantum computers, publicly accessible since November 2022, offer advanced features like dynamic qubit manipulation and room-temperature operation. The partnership is expected to significantly accelerate the development and market introduction of new medicines.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.